The clinical and bacteriological efficacy of Doripenem (DRPM) in patients with infections by Extended-spectrum beta-lactamase (ESBLs)-producing strains: non-randomized, open, label, multi-centre study.
Not Applicable
- Conditions
- Adaptable infections of DRPM
- Registration Number
- JPRN-UMIN000010722
- Lead Sponsor
- Department of Clinical Infectious Diseases, Aichi Medical Univertisy Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Hisotry of spilepsy. Neurological symptoms with convulsions. 2) History of hypersensitivity, allergy or serious adverse drug event caused by beta-lactam antibiotics. 3) Woman who are pregnant and breast-feeding or suspected to be pregnant. 4) Any other patients whose condition is inappropriate for the evaluation of this clinical study as judged by the investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method